more_vert
New research suggests that a specific group of brain cells acts as a master regulator for the brain’s waste clearance system, offering a potential new target for treating dementia.
For decades, Alzheimer’s disease research has focused on the “trash” itself — the toxic amyloid plaques and tau tangles that clutter the brain. But growing new research is asking a different question: why isn’t the trash being taken out in the first place?
The brain has its own plumbing system, known as the “glymphatic system.” It uses cerebrospinal fluid (CSF) to wash away metabolic waste, including amyloid and tau. When this system fails, toxins build up, potentially driving cognitive decline. Our latest study, published in Nature Communications, identifies a key regulator of this cleaning system: the cholinergic basal forebrain neurons.
The Pulse of the Brain
The glymphatic system doesn’t have its own pump. Instead, it relies on the rhythmic pulsing of the blood vessels to push fluid through brain tissue. In our study of aged human volunteers, we found that the strength of this coordinated blood-fluid “pulse” was linked to the health of cholinergic neurons in the basal forebrain. Essentially, the more these specific brain cells had degenerated, the more “uncoupled” the brain’s blood pulsation and fluid movement became.
Evidence from the Lab
To prove this wasn’t just a coincidence, we looked at mouse models. When we specifically removed these cholinergic neurons, the results were striking:
- Reduced pulsation: The pulsing of the arteries supplying the hippocampus — the brain’s memory centre — weakened significantly.
- Stagnant fluid: Using advanced magnetic resonance imaging (MRI) to track CSF movement, we saw that fluid began to pool and stall. The brain’s plumbing “outflow” was severely impaired, potentially leading to the kind of waste retention seen in the early stages of dementia.
Why it Matters
This discovery may be a “missing link” in our understanding of Alzheimer’s. We already know that cholinergic neurons are among the first to die in the disease — this is why drugs like donepezil are prescribed to boost their activity. However, our research found that while donepezil could change some vascular activity, it didn’t effectively “restart” the glymphatic pump in the mice. This might explain why current treatments help with symptoms but don’t stop the disease from getting worse; they aren’t fixing the “plumbing.”
Looking Ahead
The goal now is to find ways to specifically protect these neurons or manually “jumpstart” the arterial pulsing they control. By focusing on the brain’s waste clearance, we may be able to develop diagnostics that catch Alzheimer’s years before memory loss begins, simply by measuring how well the “plumbing” is performing.
It is time we stop just looking at the plaques and start looking at the pipes.
Kai-Hsiang Chuang is an Associate Professor at the University of Queensland.
The statements or opinions expressed in this article reflect the views of the authors and do not necessarily represent the official policy of the AMA, the MJA or InSight+ unless so stated.
Subscribe to the free InSight+ weekly newsletter here. It is available to all readers, not just registered medical practitioners.
If you would like to submit an article for consideration, send a Word version to mjainsight-editor@ampco.com.au.
My word. That’s why cardio exercise especially, but any exercise raising the HR is shown to be effective in preventing neuro-degenerative disease! Makes sense.